1430474-87-5

Upstream product

• 89-98-5 2-chloro-benzaldehyde 
• 885521-46-0 3-iodo-1H-indazole-5-carboxylic acid 
• 1183825-71-9 1-(2-chlorophenyl)-2-methylpropan-1-amine 
• 5408-59-3 1-(2-chlorophenyl)-2-methyl-propan-1-one 

Downstream Products

• 1430474-95-5 (S)-N-(1-(2-chlorophenyl)-2-methylpropyl)-3-iodo-1H-indazole-5-carboxamide 
• 1430474-96-6 (R)-N-(1-(2-chlorophenyl)-2-methylpropyl)-3-iodo-1H-indazole-5-carboxamide 

Relevant academic research and scientific papers

KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

The invention is a compound represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof. Values for the variables are provided herein. Also included is a pharmaceutical composition comprising the compound represented by Structural Formula (I) and a pharmaceutically acceptable carrier or diluent and methods of treating a subject with cancer with the compound of Structural Formula (I).

KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

The present teachings provide a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.

INDAZOLE COMPOUNDS AS KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

The present teaching provide indazole compounds represented by Structural Formulae (I) or (I') or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof as protein kinase inhibitors, such as T